Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19
Jonathan R Baker, Mahdi Mahdi, Dan V Nicolau Jr., View ORCID ProfileSanjay Ramakrishnan, View ORCID ProfilePeter J Barnes, Jodie L Simpson, View ORCID ProfileSteven P Cass, View ORCID ProfileRichard EK Russell, Louise E Donnelly, View ORCID ProfileMona Bafadhel
doi: https://doi.org/10.1101/2021.10.26.21265512
Jonathan R Baker
1National Heart and Lung Institute, Imperial College London, London, United Kingdom
Mahdi Mahdi
2National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), United Kingdom
3Nuffield Department of Medicine, University of Oxford, United Kingdom
Dan V Nicolau Jr.
3Nuffield Department of Medicine, University of Oxford, United Kingdom
4UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia
5School of Mathematical Sciences, Queensland University of Technology, Brisbane 4000 Australia
Sanjay Ramakrishnan
2National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), United Kingdom
3Nuffield Department of Medicine, University of Oxford, United Kingdom
6School of Medical and Health Sciences, Edith Cowan University, Perth, Australia
Peter J Barnes
1National Heart and Lung Institute, Imperial College London, London, United Kingdom
Jodie L Simpson
7School of Medicine and Public Health, Priority Centre for Healthy Lungs, University of Newcastle, Australia
Steven P Cass
2National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), United Kingdom
3Nuffield Department of Medicine, University of Oxford, United Kingdom
Richard EK Russell
2National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), United Kingdom
3Nuffield Department of Medicine, University of Oxford, United Kingdom
Louise E Donnelly
1National Heart and Lung Institute, Imperial College London, London, United Kingdom
Mona Bafadhel
2National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), United Kingdom
3Nuffield Department of Medicine, University of Oxford, United Kingdom
Data Availability
The datasets generated during and analysed during the current study are available from the corresponding author on reasonable request
Posted October 27, 2021.
Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19
Jonathan R Baker, Mahdi Mahdi, Dan V Nicolau Jr., Sanjay Ramakrishnan, Peter J Barnes, Jodie L Simpson, Steven P Cass, Richard EK Russell, Louise E Donnelly, Mona Bafadhel
medRxiv 2021.10.26.21265512; doi: https://doi.org/10.1101/2021.10.26.21265512
Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19
Jonathan R Baker, Mahdi Mahdi, Dan V Nicolau Jr., Sanjay Ramakrishnan, Peter J Barnes, Jodie L Simpson, Steven P Cass, Richard EK Russell, Louise E Donnelly, Mona Bafadhel
medRxiv 2021.10.26.21265512; doi: https://doi.org/10.1101/2021.10.26.21265512
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2337)
- Dermatology (205)
- Emergency Medicine (374)
- Epidemiology (11705)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3689)
- Geriatric Medicine (345)
- Health Economics (632)
- Health Informatics (2367)
- Health Policy (926)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3454)
- Nursing (195)
- Nutrition (520)
- Oncology (1803)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6092)
- Radiology and Imaging (1257)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (144)